Yasuhiko Yamakawa

Suggest Changes
Learn More
Lymphokine-activated killer (LAK) cell therapy frequently results in primary hypothyroidism. To elucidate the responsible mechanism, we investigated the effects of interleukin-2 (IL-2) on thyroid(More)
  • 1